Nanomaterials for Drug Targeting and Drug Delivery

Dear Colleagues,

Nanocarriers (nanoparticles, liposomes, polymers, nanoplexes and nanocapsules, etc.) have therapeutic potential to facilitate drugs’ delivery, including biological agents, small molecule drugs and nucleic acids. However, their efficiency is limited by several factors, including five consecutive processes: circulation in the blood compartments, accumulation into the target area, subsequent penetration deeply into the tissue, cellular uptake by cells, and intracellular release of drug from endosome or lysosome. For most recent nanocarriers, only < 1% could accumulate into the target tissues, cells and organelles. Hence, improving the targeting ability will inevitably improve drug efficacy and promote the clinical application of nanomedicines. The present Special Issue will focus on exploring innovative ideas or recent promising strategies to improve or regulate the targeting ability of nanocarriers for drug delivery, such as anti-cancer, bacterial infection, and vaccines, among others. Distinguished researchers are encouraged to present their studies concerning the drug fields of biomaterials, nanocarriers and controlled release, which will contribute to the smarter and more efficient design of nanodrug target delivery systems for future clinical applications.

It is our pleasure to invite all of you to submit your research to this Special Issue. Research articles, communications and review papers are welcome. To all potential authors of this Special Issue, JFB looks forward to receiving your submissions and working with you.

Dr. Chong Qiu
Prof. Dr. Mingzhen Zhang
Dr. Nianqiu Shi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Functional Biomaterials is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.